发明名称 PROBENECID FOR TREATING CARDIOMYOPATHY, SYSTOLIC CARDIAC DYSFUNCTION AND THE SYMPTOMS OF CONGESTIVE HEART FAILURE
摘要 <p>Described herein are inventions is directed to methods of treating a cardiac dysfunction and symptoms of cardiac dysfunction in a subject that includes administering an amount of probenecid effective to treat a symptom of cardiac dysfunction. The probenecid may be administered in at least one of an injection, orally, or transdermally. The amount of probenecid is sufficient to result in an improved performance on a standardized 6 minute walk test, an improved New York Heart Association (NYHA) classification, a lower diuretic dose requirement, a lower serum BNP levels, a normalization of serum sodium concentrations, and combinations thereof In an embodiment, probenecid is administered over a period of about 8 hours to about 24 hours. Probenecid may be used for short term treatments, i.e., less than a week, or it may be administered in a long term manner, i.e., over a period of weeks, months, or even years. Probenecid may be administered in an amount sufficient to treat the symptoms of cardiac dysfunction.</p>
申请公布号 EP2882431(A1) 申请公布日期 2015.06.17
申请号 EP20120781543 申请日期 2012.10.19
申请人 UNIVERSITY OF CINCINNATI 发明人 RUBINSTEIN, JACK;JONES, W., KEITH
分类号 A61K31/195;A61P9/04 主分类号 A61K31/195
代理机构 代理人
主权项
地址